| Trial ID: | L4027 |
| Source ID: | NCT03472846
|
| Associated Drug: |
Prolia, 60 Mg/Ml Subcutaneous Solution
|
| Title: |
MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Postmenopausal Osteoporosis|Diabetes Type 2
|
| Interventions: |
DRUG: Prolia, 60 Mg/mL Subcutaneous Solution|DRUG: Teriparatide
|
| Outcome Measures: |
Primary: detection of microRNA concentration in serum, influence of antiresorptive or osteoanabolic Treatment on microRNA levels in postmenopausal women with osteoporosis, 24 months | Secondary: microRNAs and changes in bone metabolism under treatment, correlation of microRNA with bone turnover markers, fracture risk, BMD, 24 months
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna | Collaborators: St. Vincent Hospital, Vienna
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
26
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2017-03-01
|
| Completion Date: |
2022-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-01-26
|
| Locations: |
Medical University Vienna; St. Vincent Hospital, Vienna, 1060, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT03472846
|
